Ledger.Open graph →
SEC Form D · filed March 27, 2020

Affinia Therapeutics Inc

Offering
$68.5M
Sold
$38.5M
Exemption
Rule 506(b)
Industry
Other
Location
Waltham, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (23)

Rick Modi · WALTHAM, MAExec · DirectorLuc Vandenberghe · WALTHAM, MADirectorRobert Aboud · Waltham, MAExecRobert Weisskoff · WALTHAM, MADirectorEdward Mathers · WALTHAM, MADirectorDavid Grayzel · WALTHAM, MADirectorSean Nolan · WALTHAM, MADirectorKabir Narang · Bellevue, WADirectorMonish Darda · Bellevue, WAExec · DirectorKaryn Smith · Bellevue, WADirectorPrem Pavoor · Bellevue, WAExecJohn Connors · Bellevue, WADirectorPenny Pritzker · Bellevue, WADirectorSamir Bodas · Bellevue, WADirectorRobert Johnson · El Segundo, CAExecStephane Lachance · Luxembourg, LuxembourgExecDaniel Galles · Jacksonville, FLDirectorKirk Moquin · Jacksonville, FLDirectorAlbert Prast · Jacksonville, FLExec · DirectorDan Wildermuth · Jacksonville, FLDirectorAng S. Zhao · Richmond, British Columbia, CanadaDirectorDaniel L. Titcomb · ST. PAUL, MNDirectorRobert Johnson · Hampton, GAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗